LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.88 | 17.25 | 2 | 534 | 0.0037 | -0.3528 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.88 | 17.25 | 1188 | 534 | 2.2229 | 1.3500 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.88 | 17.25 | 1240 | 534 | 2.3202 | 1.3704 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.85 | 17.25 | 1 | 655 | 0.0015 | -0.4188 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.85 | 17.25 | 1320 | 655 | 2.0135 | 1.2853 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.85 | 17.25 | 1 | 655 | 0.0015 | -0.4188 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.85 | 17.25 | 1380 | 655 | 2.1050 | 1.3048 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.82 | 17.25 | 1514 | 800 | 1.8913 | 1.2440 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.82 | 17.25 | 1538 | 800 | 1.9213 | 1.2504 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.79 | 17.25 | 1 | 1001 | 0.0010 | -0.3849 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.79 | 17.25 | 1673 | 1001 | 1.6703 | 1.1830 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.79 | 17.25 | 3 | 1001 | 0.0030 | -0.2581 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.79 | 17.25 | 1715 | 1001 | 1.7122 | 1.1922 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 22.76 | 17.25 | 2 | 1193 | 0.0017 | -0.2971 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 22.76 | 17.25 | 1788 | 1193 | 1.4980 | 1.1367 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 22.76 | 17.25 | 1 | 1193 | 0.0008 | -0.3725 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 22.76 | 17.25 | 1874 | 1193 | 1.5701 | 1.1532 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.73 | 17.25 | 1 | 1290 | 0.0008 | -0.3672 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.73 | 17.25 | 1898 | 1290 | 1.4711 | 1.1279 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.73 | 17.25 | 2 | 1290 | 0.0016 | -0.2926 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.73 | 17.25 | 2097 | 1290 | 1.6253 | 1.1623 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 26.70 | 17.25 | 1 | 1466 | 0.0007 | -0.3587 | MN20160310_N02 | L17 |